Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01007071 · ClinicalTrials.gov registry record · Phase 3
Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults With Growth Hormone Deficiency
A Phase 3 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 3
- Development phase
- 11
- Enrollment target
NCT01007071: Completed Phase 3 study, sponsored by Stanford University.
NCT01007071 is a Phase 3 study that has completed, run by Stanford University. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01007071, a Phase 3 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 11 participants
- Enrollment target
Study Summary
Patients with Growth hormone (GH) deficiency often report impaired quality of life and difficulty with mental functioning. It has been suggested that GH replacement in such patients leads to improvement in cognitive function. The aim of this study is to elucidate the effects of GH replacement in patients with GH deficiency on cognitive function using structural and functional neuroimaging and cognitive testing.
Interventions
- DRUG Placebo
- DRUG Human Growth Hormone (1-134)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2009-11-01 |
| Est. Completion | 2012-12-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01007071
The ClinicalTrials.gov registry entry for NCT01007071 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01007071 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01007071 about?
NCT01007071 is a clinical study titled "Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults With Growth Hormone Deficiency". Patients with Growth hormone (GH) deficiency often report impaired quality of life and difficulty with mental functioning. It has been suggested that GH replacement in such patients leads to improvement in cognitive function. The aim of this study is to elucidate the effects of GH replacement in pat...
What is the current status of trial NCT01007071?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 11 participants. The study started on 2009-11-01. Estimated completion is 2012-12-12.
What interventions are being tested in trial NCT01007071?
The interventions under investigation include: Placebo (DRUG), Human Growth Hormone (1-134) (DRUG).
Who is sponsoring clinical trial NCT01007071?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.